111 Total Liabilities 2018-2024 | YI
111 total liabilities from 2018 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
| 111 Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $472 |
| 2023 | $519 |
| 2022 | $563 |
| 2021 | $518 |
| 2020 | $402 |
| 2019 | $120 |
| 2018 | $47 |
| 2017 | $258 |
| 111 Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2024-12-31 | $472 |
| 2024-09-30 | $522 |
| 2024-06-30 | $470 |
| 2024-03-31 | $488 |
| 2023-12-31 | $519 |
| 2023-09-30 | $531 |
| 2023-06-30 | $482 |
| 2023-03-31 | $533 |
| 2022-12-31 | $563 |
| 2022-09-30 | $480 |
| 2022-06-30 | $509 |
| 2022-03-31 | $513 |
| 2021-12-31 | $518 |
| 2021-09-30 | $495 |
| 2021-06-30 | $486 |
| 2021-03-31 | $425 |
| 2020-12-31 | $402 |
| 2020-09-30 | $330 |
| 2020-06-30 | $183 |
| 2020-03-31 | $138 |
| 2019-12-31 | $120 |
| 2019-09-30 | $102 |
| 2019-06-30 | $102 |
| 2019-03-31 | $76 |
| 2018-09-30 | $52 |
| 2017-12-31 | $258 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.068B | $1.973B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.567B | 53.27 |
| Hims & Hers Health (HIMS) | United States | $11.630B | 120.84 |
| Tempus AI (TEM) | United States | $10.569B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.461B | 69.70 |
| IRhythm Technologies (IRTC) | United States | $4.396B | 0.00 |
| Privia Health (PRVA) | United States | $3.050B | 208.50 |
| Enovis (ENOV) | United States | $1.888B | 10.52 |
| Clover Health Investments (CLOV) | United States | $1.793B | 0.00 |
| Schrodinger (SDGR) | United States | $1.746B | 0.00 |
| Phreesia (PHR) | United States | $1.506B | 0.00 |
| Azenta (AZTA) | United States | $1.223B | 56.96 |
| Omnicell (OMCL) | United States | $1.208B | 21.31 |
| 10x Genomics (TXG) | United States | $1.073B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.600B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.551B | 0.00 |
| Talkspace (TALK) | United States | $0.509B | 151.00 |
| Veradigm (MDRX) | United States | $0.466B | 0.00 |
| Standard BioTools (LAB) | United States | $0.406B | 0.00 |
| TruBridge (TBRG) | United States | $0.371B | 827.00 |
| Claritev (CTEV) | United States | $0.351B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.290B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.215B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.195B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.144B | 0.00 |
| Pulmonx (LUNG) | United States | $0.136B | 0.00 |
| American Well (AMWL) | United States | $0.107B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.089B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.088B | 0.00 |
| CareCloud (CCLD) | United States | $0.081B | 3.07 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |